May 15, 2019 / 05:45PM GMT
Robert Andrew Koort - Goldman Sachs Group Inc., Research Division - MD
All right, folks. We're going to continue on with the program. For those of you who we haven't met, I'm Bob Koort. I run the chemical equity franchise here at Goldman out of Houston where our next guest hails from as well as my colleague Dylan Campbell, if you guys haven't met him. We're hoping Steve is going to get us all inspired because I was reading a Goldman Sachs report this morning about upgrading Westlake.
Steven Mark Bender - Westlake Chemical Corporation - Executive VP & CFO
I read that as well, Bob.
Questions and Answers:
Robert Andrew Koort - Goldman Sachs Group Inc., Research Division - MDOkay. Well, hopefully, you're going to agree with that. But maybe just to set some background, can you talk about the portfolio of Westlake today, where you guys play? And then hopefully, we'll elucidate why we think there might be some good opportunity here.
Steven Mark Bender - Westlake Chemical Corporation -
Trustpilot
